Riddhi Siddhi Gl

Who are the top shareholders of the Riddhi Siddhi Gl?

The top shareholders of Riddhi Siddhi Gl include Creelotex Engineers Pvt Ltd with 50.75%, Vital Connections LLP at 12.01%, and individual investors holding 9.56%. There are also two mutual fund schemes with 0.01%, and no foreign institutional investors are currently involved.

The top shareholders of Riddhi Siddhi Gl include the promoters, with Creelotex Engineers Pvt Ltd holding the largest stake at 50.75%. The highest public shareholder is Vital Connections LLP, which owns 12.01%. Additionally, individual investors collectively hold 9.56% of the shares. There are also two mutual fund schemes that hold a very small percentage (0.01%), and currently, there are no foreign institutional investors (FIIs) involved with the company.

Who are in the management team of Riddhi Siddhi Gl?

As of March 2022, the management team of Riddhi Siddhi Gl includes Ganpatraj L Chowdhary (Chairman & Managing Director), Siddharth Chowdhary (Whole-time Director), and several independent directors: R Sathyamurthi, Balveermal Singhvi, Urvi Desai, Mahendra Kumar Bhandari, and Sangita Sandeep Singhi, along with Sharad Jain as Company Secretary & Compliance Officer.

As of March 2022, the management team of Riddhi Siddhi Gl includes the following individuals:<BR><BR>1. R Sathyamurthi - Independent Director<BR>2. Ganpatraj L Chowdhary - Chairman & Managing Director<BR>3. Siddharth Chowdhary - Whole-time Director<BR>4. Balveermal Singhvi - Independent Director<BR>5. Urvi Desai - Independent Director<BR>6. Sharad Jain - Company Secretary & Compliance Officer<BR>7. Mahendra Kumar Bhandari - Independent Director<BR>8. Sangita Sandeep Singhi - Independent Director<BR><BR>Each member plays a role in guiding the company's operations and governance.

Has Riddhi Siddhi Gl declared dividend?

Yes, Riddhi Siddhi Gluco Biols Ltd has declared a 30% dividend, amounting to ₹3 per share, with an ex-date of September 17, 2024. While recent returns have been negative over the last 6 months, the company has shown significant growth in total returns over the past 5 years.

Riddhi Siddhi Gluco Biols Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3 per share<BR>- Ex-date: 17 Sep 24<BR><BR>Dividend Yield: 0.5%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -9.53%, the dividend return was 0%, resulting in a total return of -9.53%.<BR><BR>Over the past year, the price return was 7.18%, with a dividend return of 0.52%, leading to a total return of 7.7%.<BR><BR>In the 2-year period, the price return was 74.14%, the dividend return was 1.28%, culminating in a total return of 75.42%.<BR><BR>For the 3-year period, the price return was 70.73%, the dividend return was 1.64%, resulting in a total return of 72.37%.<BR><BR>In the last 4 years, the price return was 80.07%, with a dividend return of 1.69%, leading to a total return of 81.76%.<BR><BR>Finally, over the past 5 years, the price return was 132.18%, the dividend return was 2.04%, resulting in a total return of 134.22%.<BR><BR>Overall, Riddhi Siddhi Gluco Biols Ltd has declared a dividend, and while the recent returns over the last 6 months have been negative, the longer-term returns over 5 years show significant growth, indicating a positive trend in total returns despite recent fluctuations.

Is Riddhi Siddhi Gl overvalued or undervalued?

As of October 22, 2020, Riddhi Siddhi Gl is considered undervalued with a low PE ratio of 5.29 and strong recent performance, especially compared to peers like MMTC and Elitecon International, which have much higher valuations.

As of 22 October 2020, the valuation grade for Riddhi Siddhi Gl moved from very expensive to risky, indicating a shift in perception regarding its value. The company appears to be undervalued, especially when considering its low PE ratio of 5.29, a price to book value of 0.27, and a PEG ratio of 0.12. These ratios suggest that the stock may be trading at a significant discount relative to its earnings growth potential.<BR><BR>In comparison to its peers, Riddhi Siddhi Gl's valuation metrics stand out. For instance, MMTC has a PE ratio of 119.39, while Elitecon International is at 131.08, both indicating a much higher valuation than Riddhi Siddhi Gl. Additionally, the company's recent stock performance has outpaced the Sensex over the past week and month, with returns of 4.72% and 15.38% respectively, reinforcing the notion that it may be undervalued in the current market.

What is the technical trend for Riddhi Siddhi Gl?

As of June 3, 2025, the market trend is sideways with mixed signals: weekly indicators show mild bullishness while monthly indicators are mildly bearish, suggesting no strong directional bias at this time.

As of 3 June 2025, the technical trend has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different time frames. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish, indicating conflicting momentum. The Bollinger Bands are bullish on both weekly and monthly charts, suggesting potential upward movement, but daily moving averages are mildly bearish, reflecting short-term weakness. The KST shows a mildly bullish trend weekly but is bearish monthly, and Dow Theory supports a mildly bullish outlook on both time frames. Overall, the indicators suggest a sideways trend with no strong directional bias at this time.

Who are the peers of the Riddhi Siddhi Gl?

Riddhi Siddhi Gl's peers include S T C, Mehai Technology, Kothari Products, Vikas Lifecare, Sakuma Exports, Balgopal Commer., Northern Spirits, Sunrise Efficie., and Variman Global. Riddhi Siddhi Gl has a 1-year return of -9.90%, which is better than Vikas Lifecare's -50.39% but lower than its other peers.

Peers: The peers of Riddhi Siddhi Gl are S T C, Mehai Technology, Kothari Products, Vikas Lifecare, Sakuma Exports, Balgopal Commer., Northern Spirits, Sunrise Efficie., and Variman Global.<BR><BR>Quality Snapshot: Below Average management risk is observed at S T C, Mehai Technology, Kothari Products, Vikas Lifecare, and Variman Global, while Average management risk is found at Sakuma Exports, Riddhi Siddhi Gl, Balgopal Commer., and Northern Spirits. Excellent growth is noted at Mehai Technology and Northern Spirits, while Below Average growth is seen at S T C, Kothari Products, Vikas Lifecare, Sakuma Exports, Riddhi Siddhi Gl, and Variman Global, with the rest showing Average growth. Good capital structure is present at Sakuma Exports and Balgopal Commer., while Below Average capital structure is noted at S T C, Mehai Technology, Kothari Products, Vikas Lifecare, Riddhi Siddhi Gl, Northern Spirits, and Variman Global.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Mehai Technology at 398.50%, while the lowest is Vikas Lifecare at -50.39%. Riddhi Siddhi Gl's 1-year return is -9.90%, which is higher than Vikas Lifecare's but lower than all other peers. Additionally, Vikas Lifecare, Sakuma Exports, and Northern Spirits have negative six-month returns.

What does Riddhi Siddhi Gl do?

Riddhi Siddhi Gluco Biols Ltd generates and sells power through windmills and trades in agricultural and metal commodities. As of March 2025, it reported net sales of 280 Cr and a net profit of 36 Cr, with a market cap of INR 429 Cr.

Overview: <BR>Riddhi Siddhi Gluco Biols Ltd is engaged in the generation and selling of power through windmills and trading in agriculture and metal commodity items, operating within the Trading & Distributors industry as a micro-cap company.<BR><BR>History: <BR>The company was incorporated in July 1990, became a public limited company in February 1992, and changed its name to Riddhi Siddhi Gluco Biols Ltd in April 1992. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 280 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 36 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 429 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 5.00 <BR>Industry P/E: 35 <BR>Dividend Yield: 0.50% <BR>Debt-Equity: 0.04 <BR>Return on Equity: 4.95% <BR>Price to Book: 0.27 <BR><BR>Contact Details: <BR>Address: 10 Abhishree Corporate Park, BRTS Bus Stand Ambali-Bopal Rd Ahmedabad Gujarat : 380058 <BR>Tel: 91-2717-298600/01/02 <BR>Email: kinjal@riddhisiddhi.co.in <BR>Website: http://www.riddhisiddhi.co.in

How big is Riddhi Siddhi Gl?

As of 24th July, Riddhi Siddhi Gluco Biols Ltd has a market capitalization of 438.00 Cr, with net sales of 135.51 Cr and a net profit of 5.20 Cr reported in the latest four quarters. The balance sheet for March 2024 shows shareholder's funds of 1,536.78 Cr and total assets of 1,773.69 Cr.

As of 24th July, Riddhi Siddhi Gluco Biols Ltd has a market capitalization of 438.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Riddhi Siddhi Gluco Biols Ltd reported net sales of 135.51 Cr and a net profit of 5.20 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing shareholder's funds of 1,536.78 Cr and total assets of 1,773.69 Cr.

How has been the historical performance of Riddhi Siddhi Gl?

Riddhi Siddhi Gl has experienced significant fluctuations in financial performance, with net sales declining from 681.81 Cr in Mar'19 to 135.51 Cr in Mar'25, while profit before tax improved from a loss of 18.09 Cr in Mar'21 to a profit of 71.48 Cr in Mar'25. Despite volatility, recent years show signs of stabilization in profitability.

Answer:<BR>The historical performance of Riddhi Siddhi Gl shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Riddhi Siddhi Gl's net sales have seen a downward trend from Mar'19 to Mar'25, decreasing from 681.81 Cr to 135.51 Cr. Total operating income followed a similar pattern, dropping from 681.81 Cr in Mar'19 to 135.51 Cr in Mar'25. The company's total expenditure, excluding depreciation, also declined from 604.92 Cr in Mar'19 to 133.52 Cr in Mar'25. Operating profit (PBDIT) exhibited volatility, peaking at 147.30 Cr in Mar'19 before falling to 89.76 Cr in Mar'25. Profit before tax showed a recovery from a loss of 18.09 Cr in Mar'21 to a profit of 71.48 Cr in Mar'25. Profit after tax similarly improved, rising from a loss of 61.81 Cr in Mar'21 to a profit of 63.05 Cr in Mar'25. However, the consolidated net profit fluctuated significantly, with a loss of 55.54 Cr in Mar'23 and a modest profit of 5.20 Cr in Mar'25. Earnings per share (EPS) reflected this volatility, moving from 68.35 in Mar'19 to 7.29 in Mar'25, while the operating profit margin and PAT margin showed improvements in recent years, indicating a potential stabilization in profitability.

When is the next results date for Riddhi Siddhi Gluco Biols Ltd?

The next results date for Riddhi Siddhi Gluco Biols Ltd is February 7, 2026.

The next results date for Riddhi Siddhi Gluco Biols Ltd is scheduled for February 7, 2026.

Are Riddhi Siddhi Gluco Biols Ltd latest results good or bad?

Riddhi Siddhi Gluco Biols Ltd's latest results are concerning, showing a consolidated net loss of ₹1.59 crores in Q3 FY26, a significant decline from the previous quarter's profit. Despite a sequential increase in net sales, the overall financial health indicates operational challenges and low profitability, suggesting a negative outlook for investors.

The latest results for Riddhi Siddhi Gluco Biols Ltd indicate a challenging financial situation. In Q3 FY26, the company reported a consolidated net loss of ₹1.59 crores, which is a significant decline of 111.74% quarter-on-quarter and 95.59% year-on-year. This marks a stark contrast to the profit of ₹13.54 crores in the previous quarter (Q2 FY26).<BR><BR>While net sales increased by 24.86% sequentially to ₹40.08 crores from ₹32.10 crores in Q2 FY26, this figure still represents a decline of 9.59% compared to ₹44.33 crores in Q3 FY25. The operating margin also fell to a negative 13.80%, the lowest in recent quarters, highlighting severe operational challenges.<BR><BR>Moreover, the company's reliance on other income to mask operational losses raises concerns about the sustainability of its business model. The return on equity (ROE) is quite low at 4.10%, indicating weak capital efficiency.<BR><BR>Overall, these results reflect significant operational difficulties and a concerning trend in profitability, suggesting that the latest performance can be characterized as bad. Investors should approach this company with caution given the multiple red flags in its financial health.

Should I buy, sell or hold Riddhi Siddhi Gluco Biols Ltd?

Which are the latest news on Riddhi Siddhi Gl?

Why is Riddhi Siddhi Gluco Biols Ltd falling/rising?

As of 13-Feb, Riddhi Siddhi Gluco Biols Ltd's stock price is at 518.90, reflecting a 2.91% increase and outperforming its sector. Despite a significant rise over the past month and year-to-date, concerns about declining investor participation and mixed short-term trends remain.

As of 13-Feb, Riddhi Siddhi Gluco Biols Ltd's stock price is rising, currently at 518.90, reflecting a change of 14.65 (2.91%) upward. This increase is notable as the stock has outperformed its sector by 1.96% today. The stock reached an intraday high of Rs 519, indicating positive momentum during the trading session. <BR><BR>Over the past month, the stock has shown a significant gain of 21.98%, contrasting with a decline of 1.20% in the benchmark Sensex, which suggests strong relative performance. Year-to-date, the stock has increased by 23.50%, while the Sensex has decreased by 3.04%, further highlighting its resilience in the market.<BR><BR>However, it is important to note that there are some concerns regarding investor participation, as the delivery volume has decreased significantly by 72.22% compared to the 5-day average. Additionally, while the stock is trading above the 50-day and 100-day moving averages, it is below the 5-day, 20-day, and 200-day moving averages, indicating mixed short-term trends.<BR><BR>Overall, the stock's rise can be attributed to its strong performance relative to the market and sector, despite some signs of declining investor participation.